HPR57 Do Favourable Access Conditions and Policies for Biosimilars Result in Increased Consumption in the EU4 and the UK?
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1189
https://www.valueinhealthjournal.com/article/S1098-3015(22)03394-0/fulltext
Title :
HPR57 Do Favourable Access Conditions and Policies for Biosimilars Result in Increased Consumption in the EU4 and the UK?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03394-0&doi=10.1016/j.jval.2022.09.1189
First page :
Section Title :
Open access? :
No
Section Order :
10739